Join us in creating a new era
of medicine where there is a
treatment for every patient.
Publications
05/31/2021
article
Abstract 6411: Discovery of covalent ligands to novel E3 ligases enables bispecific degraders with highly differentiated protein degradation across a broad range of targets, AACR 2020
05/31/2021
article
Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer, Cell
11/21/2022
article
Vividion Therapeutics Recognized as a San Diego area ‘Top Workplaces 2022’ Award Winner by the San Diego Union-Tribune